Value through Innovation27 July 2016

Clinical Study Results

  • FLOMAX ® - Prostatic Hyperplasia
    Clinical Study Number 527.15
    Study Indication Prostatic Hyperplasia
    Product FLOMAX ®
    Generic Name Tamsulosin
    Lab Code
    Clinical Phase IV
    Study Title

    MICTUS (Multicentre investigation to characterise the effect of Tamsulosin on Urinary Symptoms): A multicentre, double-blind, randomised, parallel group study, aimed at characterising the effect of tamsulosin, an uroselective alpha1-receptor blocking agent, on the urological symptoms and their impact on general heath status and quality of life in outpatients affected by symptoptomatic benign prostatic hyperplasia: comparison with finasteride.

    Study Document Trial synopsis 527.15 english
  • FLOMAX ® - Prostatic Hyperplasia
    Clinical Study Number 527.16
    Study Indication Prostatic Hyperplasia
    Product FLOMAX ®
    Generic Name Tamsulosin
    Lab Code
    Clinical Phase IV
    Study Title

    A Forty-Five Day, Open-Label Study of the Symptomatic Relief Effects of FLOMAX® Capsules 0.4 mg Daily in Patients with the Signs and Symptoms of Benign Prostatic Hyperplasia

    Study Document Trial synopsis 527.16_CO english
  • FLOMAX ® - Prostatic Hyperplasia
    Clinical Study Number 527.17
    Study Indication Prostatic Hyperplasia
    Product FLOMAX ®
    Generic Name Tamsulosin
    Lab Code
    Clinical Phase IV
    Study Title

    An Eleven-Week, Open-Label, Randomized, Multicenter, Parallel-Design, Placebo Lead-in Study ofFLOMAX® Capsules, 0.4 mg Daily Versus HYTRIN® Capsules, 5 mg (with Titration) Daily in Patients with the Signs and Symptoms of Benign Prostatic Hyperplasia

    Study Document Trial synopsis 527.17_CO english
  • FLOMAX ® - Prostatic Hyperplasia
    Clinical Study Number 527.20
    Study Indication Prostatic Hyperplasia
    Product FLOMAX ®
    Generic Name Tamsulosin
    Lab Code
    Clinical Phase IV
    Study Title

    Effect of ALNA® (Tamsulosin) on the primary symptoms ofBPH (benign prostatic hyperplasia) syndrome

    Study Document Trial synopsis 527.20 english
  • FLOMAX ® - Prostatic Hyperplasia
    Clinical Study Number 527.26
    Study Indication Prostatic Hyperplasia
    Product FLOMAX ®
    Generic Name Tamsulosin
    Lab Code
    Clinical Phase II
    Study Title

    A two phase, double-blinded, randomized, parallel-group design, multicenter study of FLOMAX® capsules 0.4 mg versus placebo in male patients with acute urinary retention related to benign prostatic hyperplasia

    Study Document Trial synopsis 527.26 english
  • FLOMAX ® - Prostatic Hyperplasia
    Clinical Study Number 527.28
    Study Indication Prostatic Hyperplasia
    Product FLOMAX ®
    Generic Name Tamsulosin
    Lab Code
    Clinical Phase IV
    Study Title

    Evolution of patients suffering from Benign Prostatic Hyperplasia (BPH) treated with alpha-adrenergic blockade

    Study Document Trial synopsis 527.28 english
  • FLOMAX ® - Prostatic Hyperplasia
    Clinical Study Number 527.38
    Study Indication Prostatic Hyperplasia
    Product FLOMAX ®
    Generic Name Tamsulosin
    Lab Code
    Clinical Phase IV
    Study Title

    Observational study in patients with functional BPH (Benign Prostatic Hyperplasia) who switched from Phytotherapy to Alna (Tamsulosin)

    Study Document Trial synopsis 527.38 english
  • FLOMAX ® - Prostatic Hyperplasia
    Clinical Study Number 527.40
    Study Indication Prostatic Hyperplasia
    Product FLOMAX ®
    Generic Name Tamsulosin
    Lab Code
    Clinical Phase IV
    Study Title

    Comorbidity and Comedication during prescription of ALNA® (Tamsulosin) for patients with BPH (Benign Prostatic Hyperplasia)

    Study Document Trial synopsis 527.40 english
  • FLOMAX ® - Prostatic Hyperplasia
    Clinical Study Number 527.46
    Study Indication Prostatic Hyperplasia
    Product FLOMAX ®
    Generic Name Tamsulosin
    Lab Code
    Clinical Phase IV
    Study Title

    Study of convergence responses to IPSS questionnaire in patients with benign prostatic hyperplasia, and their wives/partners

    Study Document Trial synopsis 527.46 english
  • FLOMAX ® - Prostatic Hyperplasia
    Clinical Study Number 527.56
    Study Indication Prostatic Hyperplasia
    Product FLOMAX ®
    Generic Name Tamsulosin
    Lab Code
    Clinical Phase IV
    Study Title

    ALNA® -AWB in pre-treated patients with BPS

    Study Document Trial synopsis 527.56 english
  • FLOMAX ® - Prostatic Hyperplasia
    Clinical Study Number 527.57
    Study Indication Prostatic Hyperplasia
    Product FLOMAX ®
    Generic Name Tamsulosin
    Lab Code
    Clinical Phase IV
    Study Title

    Study of convergence responses to IPSS and Socio questionnaires in patients treated for benign prostatic hyperplasia.

    Study Document Trial synopsis 527.57 english
  • FLOMAX ® - Prostatic Hyperplasia
    Clinical Study Number 527.58
    Study Indication Prostatic Hyperplasia
    Product FLOMAX ®
    Generic Name Tamsulosin
    Lab Code
    Clinical Phase IV
    Study Title

    Secotex ®: Prescription Event Monitoring in patients with benign prostatic hyperplasia (BPH)

    Study Document Trial synopsis 527.58 english
  • FLOMAX ® - Prostatic Hyperplasia
    Clinical Study Number 527.64
    Study Indication Prostatic Hyperplasia
    Product FLOMAX ®
    Generic Name Tamsulosin
    Lab Code
    Clinical Phase IV
    Study Title

    Secotex ®: Prescription Event Monitoring in patients with benign prostatic hyperplasia (BPH)

    Study Document Trial synopsis 527.64 english
  • FLOMAX ® - Prostatic Hyperplasia
    Clinical Study Number 527.73
    Study Indication Prostatic Hyperplasia
    Product FLOMAX ®
    Generic Name Tamsulosin
    Lab Code
    Clinical Phase IV
    Study Title

    Observational study about the use of tamsulosin in patients with benign prostatic hyperplasia

    Study Document Trial synopsis 527.73 english
  • FLOMAX ® - Prostatic Hyperplasia
    Clinical Study Number 527.80
    Study Indication Prostatic Hyperplasia
    Product FLOMAX ®
    Generic Name Tamsulosin
    Lab Code
    Clinical Phase IV
    Study Title

    Quality of life in patients with BPH and nocturia before and after tamsulosin Ocas® treatment

    Study Document Trial synopsis 527.80_DR english

Clinical Trial Registry and structured study results. Find here protocol information for all clinical study types.

European Trial Register of EU studies.